Terms ending in 2031
Every in-force patent on Roche Diagnostics GmbH's record whose computed term ends in 2031, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,283,319 | Cannula Assemblies and Ambulatory Infusion Systems with Pressure Sensors Made of Stacked Coplanar Layers In force · High confidence | Roche Diabetes Care, Inc. | In force | High confidence | |
| US 8,219,366 | Determination of Elbow Values for PCR for Parabolic Shaped Curves In force · High confidence | Roche Molecular Systems | In force | High confidence | |
| US 8,892,886 | Method and System for Establishing Cryptographic Communications Between a Remote Device and a Medical Device In force · High confidence | Roche Diabetes Care, Inc. | In force | High confidence | |
| US 8,476,053 | Stabilized Aqueous Alpha-Galactosidase Composition and Methods Relating Thereto In force · High confidence | Roche Diagnostics Operations, Inc. | In force | High confidence | |
| US 8,383,056 | Blood Glucose Test Instrument Kit Having Modular Component Parts In force · High confidence | Roche Diabetes Care, Inc. | In force | High confidence | |
| US 9,261,510 | Detection of Primary Infections with Pathogens In force · High confidence | Roche Diagnostics Operations, Inc. | In force | High confidence | |
| US 8,219,324 | Real-Time PCR Elbow Calling by Equation-Less Algorithm In force · High confidence | Roche Molecular Systems | In force | High confidence | |
| US 8,373,851 | Measuring System and Measuring Method, in Particular for Determining Blood Glucose In force · High confidence | Roche Diabetes Care, Inc. | In force | High confidence | |
| US 8,618,948 | Automatically Operating Injection Device and Method for Determining an Injection Occlusion In force · High confidence | Roche Diabetes Care, Inc. | In force | High confidence | |
| US 8,452,545 | Method and System for Determining the Difference Between Pre-Prandial and Post-Prandial Blood Glucose Values In force · High confidence | Roche Diabetes Care, Inc. | In force | High confidence | |
| 103 more term ends in 2031 · Pro | |||||
10 of 113 patents shown. Soonest term end first, then patent number.
Pro members see all 113.
2 of these are in force and held by Roche Diagnostics GmbH.
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.